Works by Weber, Irene


Results: 53
    1
    2
    3
    4

    Antimicrobial susceptibility of Gram-negative organisms from intra abdominal infections and evolution of isolates with extended spectrum ß-lactamases in the SMART study in Spain (2002-2010).

    Published in:
    Revista Española de Quimioterapia, 2011, v. 24, n. 4, p. 223
    By:
    • Cantón, Rafael;
    • Loza, Elena;
    • Aznar, Javier;
    • Calvo, Jorge;
    • Cercenado, Emilia;
    • Cisterna, Ramón;
    • Romo, Fernando González;
    • Hontangas, José Luis López;
    • Calvo, Carmen Rubio;
    • Barrenechea, Ana Isabel Suárez;
    • Tubau, Fe;
    • Weber, Irene;
    • Yuste, Patricia;
    • Cavanillas, Rafael
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Analysis of drug resistance in HIV protease.

    Published in:
    BMC Bioinformatics, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s12859-018-2331-y
    By:
    • Pawar, Shrikant D.;
    • Freas, Christopher;
    • Weber, Irene T.;
    • Harrison, Robert W.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Front Cover: Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants (ChemMedChem 8/2018).

    Published in:
    ChemMedChem, 2018, v. 13, n. 8, p. 762, doi. 10.1002/cmdc.201800226
    By:
    • Ghosh, Arun K.;
    • Rao, Kalapala Venkateswara;
    • Nyalapatla, Prasanth R.;
    • Kovela, Satish;
    • Brindisi, Margherita;
    • Osswald, Heather L.;
    • Sekhara Reddy, Bhavanam;
    • Agniswamy, Johnson;
    • Wang, Yuan‐Fang;
    • Aoki, Manabu;
    • Hattori, Shin‐ichiro;
    • Weber, Irene T.;
    • Mitsuya, Hiroaki
    Publication type:
    Article
    36

    Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants.

    Published in:
    ChemMedChem, 2018, v. 13, n. 8, p. 803, doi. 10.1002/cmdc.201700824
    By:
    • Ghosh, Arun K.;
    • Rao, Kalapala Venkateswara;
    • Nyalapatla, Prasanth R.;
    • Kovela, Satish;
    • Brindisi, Margherita;
    • Osswald, Heather L.;
    • Sekhara Reddy, Bhavanam;
    • Agniswamy, Johnson;
    • Wang, Yuan‐Fang;
    • Aoki, Manabu;
    • Hattori, Shin‐ichiro;
    • Weber, Irene T.;
    • Mitsuya, Hiroaki
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands.

    Published in:
    ChemMedChem, 2022, v. 17, n. 9, p. 1, doi. 10.1002/cmdc.202200058
    By:
    • Ghosh, Arun K.;
    • Kovela, Satish;
    • Sharma, Ashish;
    • Shahabi, Dana;
    • Ghosh, Ajay K.;
    • Hopkins, Denver R.;
    • Yadav, Monika;
    • Johnson, Megan E.;
    • Agniswamy, Johnson;
    • Wang, Yuan‐Fang;
    • Hattori, Shin‐Ichiro;
    • Higashi‐Kuwata, Nobuyo;
    • Aoki, Manabu;
    • Amano, Masayuki;
    • Weber, Irene T.;
    • Mitsuya, Hiroaki
    Publication type:
    Article
    50